Leidos, Immunovaccine Form Zika Vaccine Development Partnership; Jerry Hogge Comments

Leidos and Canada-based clinical vaccine developer Immunovaccine have forged an agreement to jointly develop a preventive agent against the mosquito-borne Zika virus in an effort to halt the spread of the disease that has affected much of Latin America within the past year. The companies said Thursday Immunovaccine will use its DepoVax platform to create an anti-Zika vaccine and … Continue reading Leidos, Immunovaccine Form Zika Vaccine Development Partnership; Jerry Hogge Comments